ConvaTec Group PLC
LSE:CTEC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
ConvaTec Group PLC
EPS (Diluted)
ConvaTec Group PLC
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
ConvaTec Group PLC
LSE:CTEC
|
EPS (Diluted)
$0
|
CAGR 3-Years
44%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Abingdon Health PLC
LSE:ABDX
|
EPS (Diluted)
£0
|
CAGR 3-Years
51%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Tristel PLC
LSE:TSTL
|
EPS (Diluted)
£0
|
CAGR 3-Years
32%
|
CAGR 5-Years
10%
|
CAGR 10-Years
18%
|
|
|
Inspecs Group PLC
LSE:SPEC
|
EPS (Diluted)
£0
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Advanced Medical Solutions Group PLC
LSE:AMS
|
EPS (Diluted)
£0
|
CAGR 3-Years
-18%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-3%
|
|
|
Rua Life Sciences PLC
LSE:RUA
|
EPS (Diluted)
£0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
ConvaTec Group PLC
Glance View
ConvaTec Group PLC is a notable player in the realm of medical products and technologies, deftly weaving its narrative within the healthcare industry. Founded in 1978, the company has steadily established itself through strategic expansion and innovation, focusing on improving the lives of patients and enhancing healthcare delivery. The company's core business revolves around four main product categories: Advanced Wound Care, Ostomy Care, Continence and Critical Care, and Infusion Care. Each of these sectors is backed by a robust commitment to research and development, allowing ConvaTec to deliver specialized products that cater to both specific patient needs and broader healthcare system demands. ConvaTec's financial model centers around providing essential, high-quality medical solutions that ultimately support improved patient outcomes. The company garners revenue by partnering with hospitals, healthcare providers, and direct consumer channels, ensuring its products reach where they are most needed. With a global footprint spanning multiple continents, ConvaTec not only distributes its products widely but also adapts its strategy to meet the nuanced requirements of diverse markets. By aligning itself closely with caregivers and leveraging cutting-edge technology, the company maintains a sustainable economic engine through both recurring sales from consumables and long-term relationships with its institutional clients.
See Also
What is ConvaTec Group PLC's EPS (Diluted)?
EPS (Diluted)
0.1
USD
Based on the financial report for Dec 31, 2025, ConvaTec Group PLC's EPS (Diluted) amounts to 0.1 USD.
What is ConvaTec Group PLC's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
8%
Over the last year, the EPS (Diluted) growth was 0%. The average annual EPS (Diluted) growth rates for ConvaTec Group PLC have been 44% over the past three years , 8% over the past five years .